Ken Schneider, M.D, F.R.C.P (C)

Ken Schneider

Position: Radiation Oncologist
Affiliation: Windsor Regional  Cancer Program

Position: Adjunct Professor, Physics
Affiliation: University of Windsor

Position: Adjunct Professor
Affiliation: Schulich School of Medicine and Dentistry


Areas of Expertise: CNS tumours, head and neck, breast, gynecologic malignancies and sarcoma.

Brief Description of Research:

Dr. Ken Schneider served as the Chief of Oncology, Windsor Regional Hospital from 2002 to January, 2018. He continues in his role as Clinical Lead of the Radiation Oncology Program.His research focuses on clinical trials for optimizing treatment of head and neck cancer, breast cancer, gynecologic cancers, and tumors of the brain. He is the Windsor Regional Cancer Center’s Co-Representative for the National Cancer Institute of Canada (NCIC), a clinical trials institute. He has been a part of a landmark study investigating a different dose schedule of radiation for breast cancer patients after a lumpectomy to reduce the risk of local recurrence. The clinical trial examined the chronic effects of hypofractionation of radiation therapy with higher doses of radiation per fraction and found that they were almost identical to the traditional dose schedule. The effectiveness was also found to be equal. This helped to make radiation therapy more economical and more accessible to breast cancer patients.

5 Selected Publications:

Rouette, J., Gutierrez, E., O’Donnell, J., Reddeman, L., Hart, M., Foxcroft, S., Mitera, G., Warde, P., Brundage MD; Cancer Care Ontario Radiation Oncology Program Leads (Ken Schneider); Pan-Canadian Peer Review Steering Committee. (2017). Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program. International Journal of Radiation Oncology*Biology*Physics 98(3), 521-529.

Liu, L.J., Brown, S.L., Ewing, J.R., Ala, B.D., Schneider, K.M., Schlesinger, M. (2016). Estimation of Tumor Interstitial Fluid Pressure (TIFP) NoninvasivelyPLOS One. 11(7).

Pan., M., Schneider, K., Kulkarni, S., Southcott, D., Nissan, R., Kay, A., Gupta, R., Ghafoor, A., Mathews, J., Elfiki, T., Kanjeekal, S., Hirmiz, K., Yousuf, J., Springer, C., Hamm, C. (2016). Outcome of Stage 4A and 4B Head and Neck Squamous Cell Carcinoma: A Single Institution Experience with Intensity Modulated Radiotherapy and Volumetric Modulated ARC Therapy. Radiotherapy & Oncology 120(1), 54.

Pan, M., Schneider, K., Kulkarni, S., Southcott, D., Vivek, P., Gupta, R., Ghafoor, A., Mathews, J., Elfiki, T., Kanjeekal, S., Hirmiz, K., Yousuf, J., Springer, C., Hamm, C. (2014). Head and Neck Cancer Outcome in Windsor Ontario: A Border City Single Institution Experience.

Whelan, T.J., Pignol, J.P., Levin, M.N., Julian, J.A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., Perera, F., Fyles, A., Schneider, K., Gulavita, S., Freeman, C. (2010). Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. The New England Journal of Medicine: Research & Review 362, 513-520.

Wai, E.S., Groome, P.A., O’Sullivan, B., Jackson, L.D., Joshi, C., Irish, J., Bissett, R.J., Dixon, P., Eapen L, Gulavita, S.P., Hammond, J.A., Hodson, D., Mackenzie, R., Schneider, K., Warde, P.R., Mackillop, W.J. (2001). The Impact of Radiotherapy Margins on Local Control of Laryngeal Cancer. Int J Rad Oncology, Biology, Physics 50(5), 1392.